Markets:

Overview

News

Currencies

International

Treasuries

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

0.3648 -0.0194 (-5.05%)

Streaming Delayed Price Updated: 10:39 AM EDT, Aug 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ensysce Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Ensysce Biosciences to Present Clinical Dataset at Major PAINWeek Scientific Symposium

August 14, 2023

Via ACCESSWIRE

Ensysce Biosciences Reports Second Quarter 2023 Financial Results

August 11, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces IRB Approval of Key Study Protocol

August 08, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces Engagement of Alacrita Consulting

July 26, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

July 04, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

July 04, 2023

Via Benzinga

Ensysce Biosciences to Participate in Upcoming Industry Events

June 06, 2023

Via ACCESSWIRE

Ensysce Biosciences Reports First Quarter 2023 Financial Results

May 15, 2023

Via ACCESSWIRE

Why Is Ensysce Biosciences (ENSC) Stock Up 50% Today? ↗

May 09, 2023

With Ensysce Biosciences achieving testing success regarding its overdose protection drug, ENSC stock soared on the implications.

Via InvestorPlace

Why Ensysce Biosciences Stock Surged Today ↗

July 03, 2023

Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares popped Monday following positive coverage from HC Wainwright. The firm put a price target on the stock far above current levels.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

July 03, 2023

Via Benzinga

Why Li Auto Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

July 03, 2023

Gainers PolyMet Mining Corp. (NYSE: PLM) shares surged 144% to $1.92 after the company announced Glencore made a non-binding proposal to acquire the company for $2.11 per share.

Via Benzinga

Ensysce Biosciences Announces Successful Completion of Ground-Breaking Study on Overdose Protection

May 09, 2023

Via ACCESSWIRE

Ensysce CEO Dr. Lynn Kirkpatrick To Present Featured Case Study of MPAR Overdose Protection Platform Accelerated Development

April 19, 2023

Via ACCESSWIRE

Ensysce Biosciences Announces Updated Investor Presentation Available Via Investor Relations Website

April 11, 2023

Via ACCESSWIRE

Nasdaq Edges Lower; ISM Manufacturing PMI Drops In June ↗

July 03, 2023

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite trading lower on Monday. The Dow traded up 0.16% to 34,462.62 while the NASDAQ fell 0.03% to 13,784.02. The S&P 500, also...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 3, 2023 ↗

July 03, 2023

Via Benzinga

Ensysce Biosciences and Quotient Sciences to Present MPAR(R) Overdose Protection Platform at Upcoming CRS 2023 Annual Meeting and Expo

June 27, 2023

Via ACCESSWIRE

Ensysce Biosciences Regains Compliance with Nasdaq

June 13, 2023

Via ACCESSWIRE

Ensysce Biosciences Releases Updated Investor Presentation Available Via Investor Relations Website

June 07, 2023

Via ACCESSWIRE

Stocks That Hit 52-Week Lows On Friday ↗

May 19, 2023

On Friday, 63 companies hit new 52-week lows.

Via Benzinga

Ensysce Biosciences, Inc. Announces Closing of $7 Million Public Offering

May 12, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

May 10, 2023

Via Benzinga

Ensysce Biosciences, Inc. Announces Pricing of $7 Million Public Offering

May 10, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 09, 2023

Via Benzinga

Ensysce Biosciences (NASDAQ: ENSC) Successfully Completes Overdose-Protection Study

May 09, 2023

Ensysce Biosciences, Inc. (NASDAQ: ENSC) operates as a clinical-stage biotechnology company, which is focused on leveraging its proprietary technology to

Via Spotlight Growth

Why PRA Group Shares Are Trading Lower By 44%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

May 09, 2023

Gainers TScan Therapeutics, Inc. (NASDAQ: TCRX) shares gained 118% to $4.68 after the company and Amgen announced collaboration to identify novel targets in Crohn's disease.

Via Benzinga

Why Are Ensysce Biosciences Shares Are Trading Higher Today ↗

May 09, 2023

Ensysce Biosciences Inc (NASDAQ: ENSC) completed PF614-MPAR-101, a clinical study examining the company's first pain medication with overdose protection,

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 09, 2023

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9

...

17 18 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Ensysce Biosciences, Inc. - Common Stock (NQ:ENSC)

All News about Ensysce Biosciences, Inc. - Common Stock

Starting at /week.